Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹2.2 LAccepted-Finance | ₹2.2 L | L1 | Accepted-Finance L1 |
| 2 | L2₹3.9 LAccepted-Finance | ₹3.9 L | L2 | Accepted-Finance L2 |
| 3 | L3₹24.0 LAccepted-Finance | ₹24.0 L | L3 | Accepted-Finance L3 |
| 4 | L4₹33.5 LAccepted-Finance | ₹33.5 L | L4 | Accepted-Finance L4 |
| 5 | L5₹35.3 LAccepted-Finance | ₹35.3 L | L5 | Accepted-Finance L5 |
| Sl No | Description | Qty | Unit | RELIABLE PHARMA L6 | SOUTH END TRADE LINKS L2 | MEDI TRADE L4 | PREMIER PHARMA DISTRIBUTORS L5 | MEDI DARZEE HEALTHCARE L3 | Arechar Healthcare LLP L1 |
|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj. 5-Fluorouracil 250 mg/ 5 ml | 20 | Nos | 265 ₹5,300 | - | 223 ₹4,460 | 240 ₹4,800 | - | - |
| 2.00 | Inj. Bendamustine 100 mg/vial | 10 | Nos | 2,522 ₹25,220 | 890.4 ₹8,904 | 2,462 ₹24,620 | 2,421 ₹24,210 | 1,011 ₹10,110 | - |
| 3.00 | Tab. Capecitabine 500 mg | 1,000 | Nos | 71.65 ₹71,650 | 15.44 ₹15,440 | 67.23 ₹67,230 | 70 ₹70,000 | 319 ₹3.2 L | 103.5 ₹1.0 L |
| 4.00 | Inj. Carboplatin 10 mg/ml | 20 | Nos | 2,411 ₹48,220 | - | 1,923 ₹38,460 | 1,999 ₹39,980 | - | 1,290 ₹25,800 |
| 5.00 | Inj. Cisplatin 1mg/ml | 20 | Nos | 765 ₹15,300 | - | 493 ₹9,860 | 475 ₹9,500 | 74 ₹1,480 | - |
| 6.00 | Inj. Cyclophosphamide 500 mg | 20 | Nos | - | - | - | - | - | - |
| 7.00 | Inj. Docetaxel 80/120 mg | 20 | Nos | 2,990 ₹59,800 | - | 2,810 ₹56,200 | 2,790 ₹55,800 | 744 ₹14,880 | - |
| 8.00 | Inj. Doxorubicin 2 mg/ml | 20 | Nos | 6,555 ₹1.3 L | - | 6,350 ₹1.3 L | 6,300 ₹1.3 L | 199 ₹3,980 | - |
| 9.00 | Tab. Gefitinib 250 mg | 1,000 | Nos | 142 ₹1.4 L | 17.12 ₹17,120 | 123 ₹1.2 L | 115 ₹1.1 L | 330 ₹3.3 L | 40 ₹40,000 |
| 10.00 | Inj. Gemcitabine 200 mg | 30 | Nos | 496 ₹14,880 | 178.5 ₹5,355 | 390 ₹11,700 | 369 ₹11,070 | 160 ₹4,800 | 290 ₹8,700 |
Tender Value
Refer Docs
EMD Value
₹62,000
Closing Date
14 Oct 2025, 3:00 pmClosed
Director
ADMINISTRATION OF UNION TERRITORY OF LAKSHADWEEP (DIRECTORATE OF HEALTH SERVICES) KAVARATTI-682555
Procurement and Supply of Anticancer medicines required for Oncology unit of Indira Gandhi Hospital, Kavaratti, UT of Lakshadweep.
2025_UTL_3112_1
LD-09014/18/2024-Buf-UT-LKS
Open Tender
Medicines
Kavaratti
Please refer Tender documents.
4 documents required · 4 mandatory
₹500
Director, Health Services, Kvt
₹62,000
Yes
24 Apr 2026
1 Oct 2025
15 Oct 2025
1 Oct 2025
14 Oct 2025
1 Oct 2025
Inj. 5-Fluorouracil 250 mg/ 5 ml
Inj. Bendamustine 100 mg/vial
Tab. Capecitabine 500 mg
Inj. Carboplatin 10 mg/ml
Inj. Cisplatin 1mg/ml
Inj. Cyclophosphamide 500 mg
Inj. Docetaxel 80/120 mg
Inj. Doxorubicin 2 mg/ml
Tab. Gefitinib 250 mg
Inj. Gemcitabine 200 mg
Inj. Gemcitabine 1000 mg
Tab. Imatinib 400 mg
Cap. Lenalidomide 25 mg
Inj. Methotrexate 50 mg/ml
Inj. Oxaliplatin 5 mg/ml in 20 ml vial
Inj. Octreotide Depot LAR 30mg
Inj. Ondansetron 4mg/8mg
Inj. Paclitaxel 260mg/43.5 ml
Inj. Rituximab 500 mg/50ml
Inj. Rituximab 100 mg/10ml
Cap. Temozolomide 250 mg
Inj. Trastuzumab 440 mg/50 ml
Tab. Bicalutamide 50 mg
Tab. Enzalutamide 160 mg
Tab. Letrozole 2.5 mg
Inj. Leuprolide acetate 11.25 mg
Tab. Tamoxifen 20 mg
Inj. Dexamethasone 4 mg/ml
Inj. Filgrastim 300 mcg
Cap. Tramadol 100 mg
Inj. Zoledronic acid 4 mg
Tab. Granisetron 1mg
Aprepitant kit (125mg) + (80mg) + (80mg)
SOUTH END TRADE LINKS (BID ID -11216)
MEDI DARZEE HEALTHCARE (BID ID -11225)
MEDI TRADE (BID ID -11224)
PREMIER PHARMA DISTRIBUTORS (BID ID -11226)
RELIABLE PHARMA (BID ID -11229)
SOUTH END TRADE LINKS
MEDI TRADE
MEDI DARZEE HEALTHCARE
PREMIER PHARMA DISTRIBUTORS
stage.html
html • 0.05 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 1.78 MB
BOQ_3537.xls
BOQ • 0.36 MB
Download all tender documents and submit your bid